Hexarelin
His-D-Trp-Ala-Trp-D-Phe-Lys-NH2
Hexarelin is a synthetic hexapeptide belonging to the growth hormone releasing peptide (GHRP) family and is recognized as one of the most potent growth hormone secretagogues available. It binds to ghrelin receptors (GHS-R) in the hypothalamus and pituitary gland, triggering powerful growth hormone release and providing unique cardiovascular protective benefits beyond other GHRPs.
Complete Research Database
Adverse Event Frequencies (Clinical Trials)
Clinical Safety Notes
- •GI side effects typically occur during dose escalation
- •Most adverse events are mild to moderate in severity
- •Discontinuation rate due to side effects: ~5.3%
- •No increased risk of pancreatitis in clinical trials
- •Regular monitoring recommended for thyroid function
Medical Disclaimer
Hexarelin is a research chemical not approved by the FDA for human use. This information is for educational purposes only and should not replace professional medical advice. Always consult with a qualified healthcare provider before starting any peptide therapy. Individual results may vary. Not suitable for use by minors, pregnant or nursing women, or individuals with certain medical conditions.